Page last updated: 2024-10-31

nocodazole and Astrocytoma

nocodazole has been researched along with Astrocytoma in 2 studies

Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hawes, JJ1
Nerva, JD1
Reilly, KM1
Hong, FD1
Chen, J1
Donovan, S1
Schneider, N1
Nisen, PD1

Other Studies

2 other studies available for nocodazole and Astrocytoma

ArticleYear
Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds.
    Journal of biomolecular screening, 2008, Volume: 13, Issue:8

    Topics: Animals; Antineoplastic Agents; Astrocytoma; Camptothecin; Cytostatic Agents; Cytotoxins; Drug Evalu

2008
Taxol, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid progression.
    Carcinogenesis, 1999, Volume: 20, Issue:7

    Topics: Astrocytoma; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Division; Cyclin-Dependent Kinase Inh

1999